Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG GENES KEGG PATHWAY KEGG DRUG DrugBank 指定難病告示番号
1 TUBB3 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D00491 Paclitaxel 2件: 46, 85
2 TUBB3 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D00570 Colchicine 7件: 2, 42, 46, 56, 93, 210, 266
3 TUBB3 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D01068 Vinblastine 2件: 34, 65
4 TUBB3 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D02197 Vincristine 4件: 26, 34, 65, 331
5 TUBB3 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D05333 Paclitaxel 2件: 46, 85
6 TUBB3 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D08675 Vinblastine 2件: 34, 65
7 TUBB3 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D08679 Vincristine 4件: 26, 34, 65, 331
8 TUBB3 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D09587 Brentuximab vedotin 2件: 49, 51
9 TUBB3 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D11595 Belantamab mafodotin 1件: 28
10 TUBB4A 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D00491 Paclitaxel 2件: 46, 85
11 TUBB4A 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D00570 Colchicine 7件: 2, 42, 46, 56, 93, 210, 266
12 TUBB4A 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D01068 Vinblastine 2件: 34, 65
13 TUBB4A 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D02197 Vincristine 4件: 26, 34, 65, 331
14 TUBB4A 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D05333 Paclitaxel 2件: 46, 85
15 TUBB4A 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D08675 Vinblastine 2件: 34, 65
16 TUBB4A 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D08679 Vincristine 4件: 26, 34, 65, 331
17 TUBB4A 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D09587 Brentuximab vedotin 2件: 49, 51
18 TUBB4A 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D11595 Belantamab mafodotin 1件: 28
19 TUBB4B 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D00491 Paclitaxel 2件: 46, 85
20 TUBB4B 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D00570 Colchicine 7件: 2, 42, 46, 56, 93, 210, 266
21 TUBB4B 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D01068 Vinblastine 2件: 34, 65
22 TUBB4B 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D02197 Vincristine 4件: 26, 34, 65, 331
23 TUBB4B 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D05333 Paclitaxel 2件: 46, 85
24 TUBB4B 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D08675 Vinblastine 2件: 34, 65
25 TUBB4B 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D08679 Vincristine 4件: 26, 34, 65, 331
26 TUBB4B 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D09587 Brentuximab vedotin 2件: 49, 51
27 TUBB4B 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D11595 Belantamab mafodotin 1件: 28
28 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00076 Norepinephrine 1件: 22
29 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00095 Epinephrine 3件: 46, 70, 96
30 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00124 Ephedrine 1件: 11
31 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00235 Atenolol 1件: 167
32 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00255 Carvedilol 5件: 6, 57, 86, 113, 210
33 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00378 Timolol 2件: 157, 227
34 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00432 Nadolol 1件: 6
35 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00483 Propranolol 7件: 6, 158, 167, 215, 227, 278, 296
36 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00485 Pseudoephedrine 1件: 17
37 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00601 Metoprolol 6件: 17, 57, 58, 113, 193, 226
38 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00603 Timolol 2件: 157, 227
39 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00632 Dobutamine 3件: 57, 58, 215
40 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00634 Bisoprolol 3件: 67, 86, 113
41 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00636 Amiodarone 2件: 28, 127
42 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00644 Esmolol 1件: 58
43 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00996 Epinephrine 3件: 46, 70, 96
44 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D01277 Droxidopa 5件: 5, 6, 17, 169, 170
45 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D02149 Epinephrine 3件: 46, 70, 96
46 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D02342 Bisoprolol 3件: 67, 86, 113
47 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D02349 Dipivefrin 1件: 6
48 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D02358 Metoprolol 6件: 17, 57, 58, 113, 193, 226
49 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D02910 Amiodarone 2件: 28, 127
50 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D03415 Carvedilol 5件: 6, 57, 86, 113, 210
51 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D03879 Dobutamine 3件: 57, 58, 215
52 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D03880 Dobutamine 3件: 57, 58, 215
53 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D03881 Dobutamine 3件: 57, 58, 215
54 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D05011 Metoprolol 6件: 17, 57, 58, 113, 193, 226
55 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D05127 Nebivolol 4件: 17, 85, 113, 167
56 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D05206 Norepinephrine 1件: 22
57 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D05648 Pseudoephedrine 1件: 17
58 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D05649 Pseudoephedrine 1件: 17
59 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D07660 Celiprolol 1件: 168
60 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D07916 Esmolol 1件: 58
61 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D08443 Propranolol 7件: 6, 158, 167, 215, 227, 278, 296
62 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D08449 Pseudoephedrine 1件: 17
63 ADRB1 5件: Neuroactive ligand-receptor interaction, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D08600 Timolol 2件: 157, 227
64 DRD1 4件: Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease, Morphine addiction D00059 Levodopa 8件: 2, 4, 6, 17, 90, 140, 164, 201
65 DRD1 4件: Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease, Morphine addiction D00502 Pergolide 1件: 6
66 DRD1 4件: Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease, Morphine addiction D00633 Dopamine 4件: 6, 7, 74, 299
67 DRD1 4件: Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease, Morphine addiction D01044 Flupentixol 1件: 97
68 DRD1 4件: Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease, Morphine addiction D02004 Apomorphine 3件: 5, 6, 7
69 DRD1 4件: Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease, Morphine addiction D07460 Apomorphine 3件: 5, 6, 7
70 DRD1 4件: Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease, Morphine addiction D07870 Dopamine 4件: 6, 7, 74, 299
71 DRD1 4件: Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease, Morphine addiction D08339 Pergolide 1件: 6
72 DRD1 4件: Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease, Morphine addiction D09886 Dexpramipexole 1件: 2
73 DRD1 4件: Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease, Morphine addiction D11431 Tavapadon 1件: 6
74 DRD1 4件: Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease, Morphine addiction D11839 Foslevodopa 1件: 6
75 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D00059 Levodopa 8件: 2, 4, 6, 17, 90, 140, 164, 201
76 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D00136 Haloperidol 1件: 8
77 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D00270 Chlorpromazine 1件: 254
78 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D00426 Risperidone 5件: 8, 156, 179, 187, 206
79 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D00454 Olanzapine 2件: 2, 8
80 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D00458 Quetiapine 2件: 6, 13
81 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D00502 Pergolide 1件: 6
82 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D00559 Pramipexole 3件: 2, 6, 20
83 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D00560 Pimozide 1件: 2
84 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D00633 Dopamine 4件: 6, 7, 74, 299
85 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D00702 Buspirone 3件: 6, 51, 179
86 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D00726 Metoclopramide 1件: 51
87 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D00780 Bromocriptine 2件: 6, 74
88 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D00784 Ropinirole 4件: 2, 6, 74, 309
89 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D00789 Chlorpromazine 1件: 254
90 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D00799 Trifluoperazine 2件: 283, 284
91 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D00987 Cabergoline 3件: 6, 74, 75
92 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D01044 Flupentixol 1件: 97
93 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D01164 Aripiprazole 2件: 6, 206
94 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D01226 Sulpiride 5件: 2, 6, 17, 46, 70
95 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D01348 Terguride 2件: 51, 86
96 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D01448 Trifluoperazine 2件: 283, 284
97 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D01462 Lisuride 2件: 6, 86
98 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D01745 Domperidone 5件: 6, 13, 17, 51, 230
99 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D01898 Haloperidol 1件: 8
100 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D02004 Apomorphine 3件: 5, 6, 7
101 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D02213 Metoclopramide 1件: 51
102 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D03165 Bromocriptine 2件: 6, 74
103 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D03274 Chlorpromazine 1件: 254
104 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D04034 Chlorpromazine 1件: 254
105 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D05008 Metoclopramide 1件: 51
106 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D05575 Pramipexole 3件: 2, 6, 20
107 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D05768 Rotigotine 2件: 6, 127
108 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D06623 Olanzapine 2件: 2, 8
109 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D07305 Piribedil 1件: 6
110 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D07309 Melperone 1件: 6
111 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D07460 Apomorphine 3件: 5, 6, 7
112 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D07593 Buspirone 3件: 6, 51, 179
113 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D07868 Domperidone 5件: 6, 13, 17, 51, 230
114 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D07870 Dopamine 4件: 6, 7, 74, 299
115 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D08132 Lisuride 2件: 6, 86
116 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D08339 Pergolide 1件: 6
117 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D08456 Quetiapine 2件: 6, 13
118 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D08489 Ropinirole 4件: 2, 6, 74, 309
119 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D08549 Sulpiride 5件: 2, 6, 17, 46, 70
120 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D08590 Tiapride 1件: 8
121 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D08636 Trifluoperazine 2件: 283, 284
122 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D09397 Pardoprunox 1件: 6
123 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D09886 Dexpramipexole 1件: 2
124 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D09953 Pridopidine 3件: 2, 6, 8
125 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D09997 Cariprazine 1件: 21
126 DRD2 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Parkinson disease D11839 Foslevodopa 1件: 6
127 EGFR 28件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, HIF-1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, GnRH signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, Shigellosis, Hepatitis C, Human cytomegalovirus infection, Human papillomavirus infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Pancreatic cancer, Glioma, Prostate cancer, Melanoma, Non-small cell lung cancer, Hepatocellular carcinoma, Gastric cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D01977 Gefitinib 1件: 75
128 EGFR 28件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, HIF-1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, GnRH signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, Shigellosis, Hepatitis C, Human cytomegalovirus infection, Human papillomavirus infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Pancreatic cancer, Glioma, Prostate cancer, Melanoma, Non-small cell lung cancer, Hepatocellular carcinoma, Gastric cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D03455 Cetuximab 5件: 34, 51, 86, 89, 331
129 EGFR 28件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, HIF-1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, GnRH signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, Shigellosis, Hepatitis C, Human cytomegalovirus infection, Human papillomavirus infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Pancreatic cancer, Glioma, Prostate cancer, Melanoma, Non-small cell lung cancer, Hepatocellular carcinoma, Gastric cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D04023 Erlotinib 1件: 94
130 EGFR 28件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, HIF-1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, GnRH signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, Shigellosis, Hepatitis C, Human cytomegalovirus infection, Human papillomavirus infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Pancreatic cancer, Glioma, Prostate cancer, Melanoma, Non-small cell lung cancer, Hepatocellular carcinoma, Gastric cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D04024 Lapatinib 3件: 34, 74, 75
131 EGFR 28件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, HIF-1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, GnRH signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, Shigellosis, Hepatitis C, Human cytomegalovirus infection, Human papillomavirus infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Pancreatic cancer, Glioma, Prostate cancer, Melanoma, Non-small cell lung cancer, Hepatocellular carcinoma, Gastric cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D07907 Erlotinib 1件: 94
132 EGFR 28件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, HIF-1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, GnRH signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, Shigellosis, Hepatitis C, Human cytomegalovirus infection, Human papillomavirus infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Pancreatic cancer, Glioma, Prostate cancer, Melanoma, Non-small cell lung cancer, Hepatocellular carcinoma, Gastric cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D08108 Lapatinib 3件: 34, 74, 75
133 EGFR 28件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, HIF-1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, GnRH signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, Shigellosis, Hepatitis C, Human cytomegalovirus infection, Human papillomavirus infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Pancreatic cancer, Glioma, Prostate cancer, Melanoma, Non-small cell lung cancer, Hepatocellular carcinoma, Gastric cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D11251 Icotinib 1件: 34
134 EGFR 28件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, HIF-1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, GnRH signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, Shigellosis, Hepatitis C, Human cytomegalovirus infection, Human papillomavirus infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Pancreatic cancer, Glioma, Prostate cancer, Melanoma, Non-small cell lung cancer, Hepatocellular carcinoma, Gastric cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D11772 Tesevatinib 1件: 67
135 TUBB 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D00491 Paclitaxel 2件: 46, 85
136 TUBB 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D00570 Colchicine 7件: 2, 42, 46, 56, 93, 210, 266
137 TUBB 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D01068 Vinblastine 2件: 34, 65
138 TUBB 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D02197 Vincristine 4件: 26, 34, 65, 331
139 TUBB 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D05333 Paclitaxel 2件: 46, 85
140 TUBB 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D08675 Vinblastine 2件: 34, 65
141 TUBB 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D08679 Vincristine 4件: 26, 34, 65, 331
142 TUBB 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D09587 Brentuximab vedotin 2件: 49, 51
143 TUBB 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D11595 Belantamab mafodotin 1件: 28
144 GUCY1A2 9件: Purine metabolism, Metabolic pathways, Vascular smooth muscle contraction, Gap junction, Platelet activation, Long-term depression, Oxytocin signaling pathway, Renin secretion, Salivary secretion D00517 Amyl Nitrite 1件: 58
145 GUCY1A2 9件: Purine metabolism, Metabolic pathways, Vascular smooth muscle contraction, Gap junction, Platelet activation, Long-term depression, Oxytocin signaling pathway, Renin secretion, Salivary secretion D09572 Riociguat 6件: 51, 84, 86, 88, 225, 299
146 GUCY1A1 9件: Purine metabolism, Metabolic pathways, Vascular smooth muscle contraction, Gap junction, Platelet activation, Long-term depression, Oxytocin signaling pathway, Renin secretion, Salivary secretion D00517 Amyl Nitrite 1件: 58
147 GUCY1A1 9件: Purine metabolism, Metabolic pathways, Vascular smooth muscle contraction, Gap junction, Platelet activation, Long-term depression, Oxytocin signaling pathway, Renin secretion, Salivary secretion D09572 Riociguat 6件: 51, 84, 86, 88, 225, 299
148 GUCY1B1 9件: Purine metabolism, Metabolic pathways, Vascular smooth muscle contraction, Gap junction, Platelet activation, Long-term depression, Oxytocin signaling pathway, Renin secretion, Salivary secretion D00517 Amyl Nitrite 1件: 58
149 GUCY1B1 9件: Purine metabolism, Metabolic pathways, Vascular smooth muscle contraction, Gap junction, Platelet activation, Long-term depression, Oxytocin signaling pathway, Renin secretion, Salivary secretion D09572 Riociguat 6件: 51, 84, 86, 88, 225, 299
150 HTR2A 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D00270 Chlorpromazine 1件: 254
151 HTR2A 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D00274 Cisapride 1件: 13
152 HTR2A 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D00283 Clozapine 1件: 6
153 HTR2A 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D00426 Risperidone 5件: 8, 156, 179, 187, 206
154 HTR2A 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D00454 Olanzapine 2件: 2, 8
155 HTR2A 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D00458 Quetiapine 2件: 6, 13
156 HTR2A 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D00789 Chlorpromazine 1件: 254
157 HTR2A 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D00820 Trazodone 1件: 2
158 HTR2A 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D01164 Aripiprazole 2件: 6, 206
159 HTR2A 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D02092 Cisapride 1件: 13
160 HTR2A 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D03274 Chlorpromazine 1件: 254
161 HTR2A 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D04034 Chlorpromazine 1件: 254
162 HTR2A 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D06623 Olanzapine 2件: 2, 8
163 HTR2A 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D07945 Fenfluramine 4件: 140, 144, 145, 149
164 HTR2A 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D08456 Quetiapine 2件: 6, 13
165 HTR2A 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D08626 Trazodone 1件: 2
166 HTR2A 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D09645 Nelotanserin 1件: 6
167 HTR2A 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D09997 Cariprazine 1件: 21
168 HTR2B 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D00270 Chlorpromazine 1件: 254
169 HTR2B 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D00454 Olanzapine 2件: 2, 8
170 HTR2B 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D00789 Chlorpromazine 1件: 254
171 HTR2B 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D00820 Trazodone 1件: 2
172 HTR2B 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D03274 Chlorpromazine 1件: 254
173 HTR2B 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D04034 Chlorpromazine 1件: 254
174 HTR2B 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D06623 Olanzapine 2件: 2, 8
175 HTR2B 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D07945 Fenfluramine 4件: 140, 144, 145, 149
176 HTR2B 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D08626 Trazodone 1件: 2
177 HTR2C 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D00270 Chlorpromazine 1件: 254
178 HTR2C 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D00283 Clozapine 1件: 6
179 HTR2C 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D00454 Olanzapine 2件: 2, 8
180 HTR2C 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D00789 Chlorpromazine 1件: 254
181 HTR2C 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D00820 Trazodone 1件: 2
182 HTR2C 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D02578 Agomelatine 1件: 6
183 HTR2C 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D03274 Chlorpromazine 1件: 254
184 HTR2C 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D04034 Chlorpromazine 1件: 254
185 HTR2C 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D06623 Olanzapine 2件: 2, 8
186 HTR2C 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D07945 Fenfluramine 4件: 140, 144, 145, 149
187 HTR2C 4件: Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D08626 Trazodone 1件: 2
188 TUBB8 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D00491 Paclitaxel 2件: 46, 85
189 TUBB8 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D00570 Colchicine 7件: 2, 42, 46, 56, 93, 210, 266
190 TUBB8 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D01068 Vinblastine 2件: 34, 65
191 TUBB8 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D02197 Vincristine 4件: 26, 34, 65, 331
192 TUBB8 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D05333 Paclitaxel 2件: 46, 85
193 TUBB8 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D08675 Vinblastine 2件: 34, 65
194 TUBB8 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D08679 Vincristine 4件: 26, 34, 65, 331
195 TUBB8 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D09587 Brentuximab vedotin 2件: 49, 51
196 TUBB8 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D11595 Belantamab mafodotin 1件: 28
197 TUBB2B 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D00491 Paclitaxel 2件: 46, 85
198 TUBB2B 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D00570 Colchicine 7件: 2, 42, 46, 56, 93, 210, 266
199 TUBB2B 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D01068 Vinblastine 2件: 34, 65
200 TUBB2B 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D02197 Vincristine 4件: 26, 34, 65, 331
201 TUBB2B 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D05333 Paclitaxel 2件: 46, 85
202 TUBB2B 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D08675 Vinblastine 2件: 34, 65
203 TUBB2B 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D08679 Vincristine 4件: 26, 34, 65, 331
204 TUBB2B 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D09587 Brentuximab vedotin 2件: 49, 51
205 TUBB2B 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D11595 Belantamab mafodotin 1件: 28
206 PDGFRA 14件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, Human cytomegalovirus infection, Pathways in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Melanoma D01441 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162
207 PDGFRA 14件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, Human cytomegalovirus infection, Pathways in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Melanoma D06402 Sunitinib 2件: 28, 34
208 PDGFRA 14件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, Human cytomegalovirus infection, Pathways in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Melanoma D08066 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162
209 PDGFRA 14件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, Human cytomegalovirus infection, Pathways in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Melanoma D08552 Sunitinib 2件: 28, 34
210 PDGFRA 14件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, Human cytomegalovirus infection, Pathways in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Melanoma D08953 Nilotinib 5件: 6, 8, 34, 51, 86
211 PDGFRA 14件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, Human cytomegalovirus infection, Pathways in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Melanoma D10481 Nintedanib 5件: 51, 85, 89, 227, 228
212 PDGFRB 14件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, Human papillomavirus infection, Pathways in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Melanoma D03658 Dasatinib 2件: 51, 85
213 PDGFRB 14件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, Human papillomavirus infection, Pathways in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Melanoma D06272 Sorafenib 2件: 34, 86
214 PDGFRB 14件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, Human papillomavirus infection, Pathways in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Melanoma D06402 Sunitinib 2件: 28, 34
215 PDGFRB 14件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, Human papillomavirus infection, Pathways in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Melanoma D06414 Dasatinib 2件: 51, 85
216 PDGFRB 14件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, Human papillomavirus infection, Pathways in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Melanoma D08524 Sorafenib 2件: 34, 86
217 PDGFRB 14件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, Human papillomavirus infection, Pathways in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Melanoma D08552 Sunitinib 2件: 28, 34
218 PDGFRB 14件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, Human papillomavirus infection, Pathways in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Melanoma D08953 Nilotinib 5件: 6, 8, 34, 51, 86
219 PDGFRB 14件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, Human papillomavirus infection, Pathways in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Melanoma D10481 Nintedanib 5件: 51, 85, 89, 227, 228
220 MAP2K1 59件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, HIF-1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, Oocyte meiosis, mTOR signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Osteoclast differentiation, Gap junction, Signaling pathways regulating pluripotency of stem cells, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, TNF signaling pathway, Long-term potentiation, Neurotrophin signaling pathway, Serotonergic synapse, Long-term depression, Regulation of actin cytoskeleton, Insulin signaling pathway, GnRH signaling pathway, Progesterone-mediated oocyte maturation, Melanogenesis, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, GnRH secretion, Growth hormone synthesis, secretion and action, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Hepatitis C, Hepatitis B, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Pancreatic cancer, Glioma, Prostate cancer, Thyroid cancer, Melanoma, Non-small cell lung cancer, Hepatocellular carcinoma, Gastric cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D09666 Selumetinib 1件: 34
221 MAP2K1 59件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, HIF-1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, Oocyte meiosis, mTOR signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Osteoclast differentiation, Gap junction, Signaling pathways regulating pluripotency of stem cells, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, TNF signaling pathway, Long-term potentiation, Neurotrophin signaling pathway, Serotonergic synapse, Long-term depression, Regulation of actin cytoskeleton, Insulin signaling pathway, GnRH signaling pathway, Progesterone-mediated oocyte maturation, Melanogenesis, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, GnRH secretion, Growth hormone synthesis, secretion and action, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Hepatitis C, Hepatitis B, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Pancreatic cancer, Glioma, Prostate cancer, Thyroid cancer, Melanoma, Non-small cell lung cancer, Hepatocellular carcinoma, Gastric cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D10175 Trametinib 4件: 2, 34, 279, 280
222 MAP2K1 59件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, HIF-1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, Oocyte meiosis, mTOR signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Osteoclast differentiation, Gap junction, Signaling pathways regulating pluripotency of stem cells, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, TNF signaling pathway, Long-term potentiation, Neurotrophin signaling pathway, Serotonergic synapse, Long-term depression, Regulation of actin cytoskeleton, Insulin signaling pathway, GnRH signaling pathway, Progesterone-mediated oocyte maturation, Melanogenesis, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, GnRH secretion, Growth hormone synthesis, secretion and action, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Hepatitis C, Hepatitis B, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Pancreatic cancer, Glioma, Prostate cancer, Thyroid cancer, Melanoma, Non-small cell lung cancer, Hepatocellular carcinoma, Gastric cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D10405 Cobimetinib 1件: 280
223 MAP2K1 59件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, HIF-1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, Oocyte meiosis, mTOR signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Osteoclast differentiation, Gap junction, Signaling pathways regulating pluripotency of stem cells, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, TNF signaling pathway, Long-term potentiation, Neurotrophin signaling pathway, Serotonergic synapse, Long-term depression, Regulation of actin cytoskeleton, Insulin signaling pathway, GnRH signaling pathway, Progesterone-mediated oocyte maturation, Melanogenesis, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, GnRH secretion, Growth hormone synthesis, secretion and action, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Hepatitis C, Hepatitis B, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Pancreatic cancer, Glioma, Prostate cancer, Thyroid cancer, Melanoma, Non-small cell lung cancer, Hepatocellular carcinoma, Gastric cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D10604 Binimetinib 1件: 34
224 MAP2K2 52件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, HIF-1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Gap junction, Signaling pathways regulating pluripotency of stem cells, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, Long-term potentiation, Neurotrophin signaling pathway, Long-term depression, Regulation of actin cytoskeleton, Insulin signaling pathway, GnRH signaling pathway, Melanogenesis, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, GnRH secretion, Growth hormone synthesis, secretion and action, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Hepatitis C, Hepatitis B, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Glioma, Prostate cancer, Thyroid cancer, Melanoma, Non-small cell lung cancer, Hepatocellular carcinoma, Gastric cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D09666 Selumetinib 1件: 34
225 MAP2K2 52件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, HIF-1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Gap junction, Signaling pathways regulating pluripotency of stem cells, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, Long-term potentiation, Neurotrophin signaling pathway, Long-term depression, Regulation of actin cytoskeleton, Insulin signaling pathway, GnRH signaling pathway, Melanogenesis, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, GnRH secretion, Growth hormone synthesis, secretion and action, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Hepatitis C, Hepatitis B, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Glioma, Prostate cancer, Thyroid cancer, Melanoma, Non-small cell lung cancer, Hepatocellular carcinoma, Gastric cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D10175 Trametinib 4件: 2, 34, 279, 280
226 MAP2K2 52件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, HIF-1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Gap junction, Signaling pathways regulating pluripotency of stem cells, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, Long-term potentiation, Neurotrophin signaling pathway, Long-term depression, Regulation of actin cytoskeleton, Insulin signaling pathway, GnRH signaling pathway, Melanogenesis, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, GnRH secretion, Growth hormone synthesis, secretion and action, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Hepatitis C, Hepatitis B, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Glioma, Prostate cancer, Thyroid cancer, Melanoma, Non-small cell lung cancer, Hepatocellular carcinoma, Gastric cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D10405 Cobimetinib 1件: 280
227 MAP2K2 52件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, HIF-1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Gap junction, Signaling pathways regulating pluripotency of stem cells, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, Long-term potentiation, Neurotrophin signaling pathway, Long-term depression, Regulation of actin cytoskeleton, Insulin signaling pathway, GnRH signaling pathway, Melanogenesis, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, GnRH secretion, Growth hormone synthesis, secretion and action, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Hepatitis C, Hepatitis B, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Glioma, Prostate cancer, Thyroid cancer, Melanoma, Non-small cell lung cancer, Hepatocellular carcinoma, Gastric cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D10604 Binimetinib 1件: 34
228 RAF1 53件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Gap junction, Signaling pathways regulating pluripotency of stem cells, Neutrophil extracellular trap formation, JAK-STAT signaling pathway, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, Long-term potentiation, Neurotrophin signaling pathway, Serotonergic synapse, Long-term depression, Regulation of actin cytoskeleton, Insulin signaling pathway, GnRH signaling pathway, Progesterone-mediated oocyte maturation, Melanogenesis, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, GnRH secretion, Growth hormone synthesis, secretion and action, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Tuberculosis, Hepatitis C, Hepatitis B, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Pancreatic cancer, Glioma, Prostate cancer, Melanoma, Non-small cell lung cancer, Hepatocellular carcinoma, Gastric cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D06272 Sorafenib 2件: 34, 86
229 RAF1 53件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Gap junction, Signaling pathways regulating pluripotency of stem cells, Neutrophil extracellular trap formation, JAK-STAT signaling pathway, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, Long-term potentiation, Neurotrophin signaling pathway, Serotonergic synapse, Long-term depression, Regulation of actin cytoskeleton, Insulin signaling pathway, GnRH signaling pathway, Progesterone-mediated oocyte maturation, Melanogenesis, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, GnRH secretion, Growth hormone synthesis, secretion and action, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Tuberculosis, Hepatitis C, Hepatitis B, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Pancreatic cancer, Glioma, Prostate cancer, Melanoma, Non-small cell lung cancer, Hepatocellular carcinoma, Gastric cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D08524 Sorafenib 2件: 34, 86
230 SRC 25件: Rap1 signaling pathway, Mitophagy - animal, VEGF signaling pathway, Tight junction, Gap junction, Platelet activation, Neutrophil extracellular trap formation, Inflammatory mediator regulation of TRP channels, Regulation of actin cytoskeleton, GnRH signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Pathogenic Escherichia coli infection, Shigellosis, Yersinia infection, Tuberculosis, Hepatitis B, Human cytomegalovirus infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Viral carcinogenesis, Proteoglycans in cancer, Lipid and atherosclerosis D03252 Bosutinib 2件: 2, 67
231 SRC 25件: Rap1 signaling pathway, Mitophagy - animal, VEGF signaling pathway, Tight junction, Gap junction, Platelet activation, Neutrophil extracellular trap formation, Inflammatory mediator regulation of TRP channels, Regulation of actin cytoskeleton, GnRH signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Pathogenic Escherichia coli infection, Shigellosis, Yersinia infection, Tuberculosis, Hepatitis B, Human cytomegalovirus infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Viral carcinogenesis, Proteoglycans in cancer, Lipid and atherosclerosis D03658 Dasatinib 2件: 51, 85
232 SRC 25件: Rap1 signaling pathway, Mitophagy - animal, VEGF signaling pathway, Tight junction, Gap junction, Platelet activation, Neutrophil extracellular trap formation, Inflammatory mediator regulation of TRP channels, Regulation of actin cytoskeleton, GnRH signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Pathogenic Escherichia coli infection, Shigellosis, Yersinia infection, Tuberculosis, Hepatitis B, Human cytomegalovirus infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Viral carcinogenesis, Proteoglycans in cancer, Lipid and atherosclerosis D06414 Dasatinib 2件: 51, 85
233 SRC 25件: Rap1 signaling pathway, Mitophagy - animal, VEGF signaling pathway, Tight junction, Gap junction, Platelet activation, Neutrophil extracellular trap formation, Inflammatory mediator regulation of TRP channels, Regulation of actin cytoskeleton, GnRH signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Pathogenic Escherichia coli infection, Shigellosis, Yersinia infection, Tuberculosis, Hepatitis B, Human cytomegalovirus infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Viral carcinogenesis, Proteoglycans in cancer, Lipid and atherosclerosis D09664 Saracatinib 3件: 6, 89, 272
234 TUBB2A 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D00491 Paclitaxel 2件: 46, 85
235 TUBB2A 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D00570 Colchicine 7件: 2, 42, 46, 56, 93, 210, 266
236 TUBB2A 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D01068 Vinblastine 2件: 34, 65
237 TUBB2A 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D02197 Vincristine 4件: 26, 34, 65, 331
238 TUBB2A 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D05333 Paclitaxel 2件: 46, 85
239 TUBB2A 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D08675 Vinblastine 2件: 34, 65
240 TUBB2A 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D08679 Vincristine 4件: 26, 34, 65, 331
241 TUBB2A 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D09587 Brentuximab vedotin 2件: 49, 51
242 TUBB2A 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D11595 Belantamab mafodotin 1件: 28
243 TUBB1 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D00491 Paclitaxel 2件: 46, 85
244 TUBB1 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D00570 Colchicine 7件: 2, 42, 46, 56, 93, 210, 266
245 TUBB1 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D01068 Vinblastine 2件: 34, 65
246 TUBB1 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D02197 Vincristine 4件: 26, 34, 65, 331
247 TUBB1 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D05333 Paclitaxel 2件: 46, 85
248 TUBB1 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D08675 Vinblastine 2件: 34, 65
249 TUBB1 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D08679 Vincristine 4件: 26, 34, 65, 331
250 TUBB1 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D09587 Brentuximab vedotin 2件: 49, 51
251 TUBB1 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D11595 Belantamab mafodotin 1件: 28
252 TUBB6 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D00491 Paclitaxel 2件: 46, 85
253 TUBB6 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D00570 Colchicine 7件: 2, 42, 46, 56, 93, 210, 266
254 TUBB6 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D01068 Vinblastine 2件: 34, 65
255 TUBB6 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D02197 Vincristine 4件: 26, 34, 65, 331
256 TUBB6 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D05333 Paclitaxel 2件: 46, 85
257 TUBB6 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D08675 Vinblastine 2件: 34, 65
258 TUBB6 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D08679 Vincristine 4件: 26, 34, 65, 331
259 TUBB6 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D09587 Brentuximab vedotin 2件: 49, 51
260 TUBB6 8件: Phagosome, Gap junction, Parkinson disease, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection D11595 Belantamab mafodotin 1件: 28